Biomedical subjects

W K Hsieh

Publications and source records attributed to W K Hsieh.

4 recordsLinked to original sources

PubMed1999

Seroprevalence of CMV antibodies in a blood donor population and premature neonates in the south-central Taiwan.

Infection of cytomegalovirus (CMV) via contaminated blood may endanger immunocompromised patients that require transfusion therapy. The aim of this study is to determine the prevalence of CMV antibodies in the blood donor population in Southern-central Taiwan. A total of 1800 consecutive sera, obtained from Tainan Blood Center of Chinese Blood Services Foundation (CBSF), were tested for CMV antibodies by two commercial enzyme immunoassays (EIAs). Of the sera tested, 150 (8.3%) were found to be CMV seronegative. The frequency of CMV seropositivity revealed no significant difference between male and female donors. The frequency of CMV seronegativity showed a stepwise decrease with the increase of donor age. In addition, the prevalence of HBsAg, antibodies to hepatitis C virus (anti-HCV), antibodies to human immunodeficiency viruses type 1 and 2 (anti-HIV 1 + 2) and antibodies to human T-cell lymphotropic viruses type I and II (anti-HTLV I/II) were compared between CMV seropositive and seronegative groups. Our results showed that there was no significant difference in seroprevalence of these markers between CMV seropositive and seronegative groups. Our findings also showed that six out of twenty (30.0%) premature neonates were CMV-seropositive. These premature specimens and those EIA discrepancy samples were confirmed by specific nucleic acid amplification using polymerase chain reaction (PCR). Our results suggest that a program which aims to supply CMV seronegative blood or blood components to the patients, should not solely depend on current antibody screening methods in an area where CMV infection is highly endemic. Amendments such as PCR testing, leukocyte reduction by filtration before transfusion may be more practical.

Adolescent↗

PubMed1996

Antenatal diagnosis and early surgery for choledochal cyst: a report of two cases.

Since the advent of routine antenatal sonography to detect fetal abnormalities, two cases of choledochal cyst have been found prenatally in our hospital. The first presented when a choledochal cyst was demonstrated at 31 weeks of gestation, and a firm diagnosis established within 2 days of birth. Technetium 99m disofenin (DISIDA) cholescintigram revealed delayed visualization of the small bowel. The second case was found by ultrasound examination at 21 weeks of gestation to have a choledochal cyst, and diagnosis was confirmed within 3 days of birth. DISIDA scintigram demonstrated complete obstruction of the extrahepatic biliary tree. Both infants received early excision of the cyst at the ages of three and four days respectively. The postoperative course was quite smooth, and there were no abnormal symptoms after follow up of four and two years, respectively. Neonates with distal common bile duct obstruction in association with presumed choledochal cyst should have prompt surgical exploration, and early excision of the cyst is a safe procedure in the newborn.

Adult↗

PubMed1993

Prenatal cytogenetic diagnosis by amniocentesis before 15 weeks' gestation.

Three hundred and ten early amniocenteses before 15 weeks' gestation, including one set of triplets and four twins, were performed for prenatal cytogenetic diagnosis. There was a 100% success rate in obtaining amniotic fluid and 99.4% success rate in achieving amniotic cell cultures. The mean time from amniocentesis to cell harvest by the in situ culture method was 11.3 days. A total 13 abnormal fetal karyotypes were diagnosed. The total fetal loss rate (spontaneous abortion, elective termination and late loss) was 4.5%, while miscarriage within two weeks after amniocentesis occurred in three cases (1%). Early amniocentesis combined with in situ cell culture is a safe, rapid and effective technique for early prenatal cytogenetic diagnosis.

Abortion, Spontaneous↗

PubMed1992

[Clinical experience of GDM screening program].

From Jan. 1985 to Jun. 1990, 2561 pregnant women attending our prenatal clinic were screened for gestational diabetes. A 50-gm, 1-hour glucose challenge test was given and 470 patients (18.4%) showed plasma glucose values greater than or equal to 140 mg/dl. These women were subjected to a further 3-hr 100-gm OGTT to diagnose diabetes using O'Sullivans' criteria. Of these 470 cases, 80 (3.1%) of total cases were shown to be diabetic. Strict glycemic control with a fasting plasma sugar under 105 mg/dl and postprandial sugar under 120 mg/dl was conducted using diet and insulin in all cases. We compared the perinatal outcome of GDM pregnant women with normal pregnant women. Statistically, there was no significant difference. This study clearly demonstrates that a GDM screening program should be recommended for every pregnant woman. Prompt glycemic control should be given for all diabetic mothers to optimize the perinatal outcome.

Adult↗